David J. Woodhouse

Insider Reports History

Entity
Individual
Location
630 Gateway Blvd., South San Francisco, CA
Signature
/s/Charles Williams, Attorney-in-Fact for David J Woodhouse
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David J. Woodhouse:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NGM BIOPHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 0 $0 $1.34 Apr 5, 2024 Direct
NGM BIOPHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 0 $0 $1.34 Apr 5, 2024 Indirect
NGM BIOPHARMACEUTICALS INC Chief Executive Officer, Director Restricted Stock Unit 0 $0 $1.34 Apr 5, 2024 Direct
Surrozen, Inc./DE Director Option (right to buy) 1.33K Jun 5, 2024 Direct
NGM BIOPHARMACEUTICALS INC Chief Executive Officer, Director Stock Option (Right to Buy) 0 Apr 5, 2024 Direct

Insider Reports Filed by David J. Woodhouse

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SRZN Surrozen, Inc./DE Jun 5, 2024 1 $0 4 Jun 6, 2024 Director
NGM NGM BIOPHARMACEUTICALS INC Apr 5, 2024 13 $0 4 Apr 8, 2024 Chief Executive Officer, Director
NGM NGM BIOPHARMACEUTICALS INC Jan 16, 2024 1 -$17.5K 4 Jan 18, 2024 CHIEF EXECUTIVE OFFICER, Director
NGM NGM BIOPHARMACEUTICALS INC Nov 6, 2023 16 $0 4 Nov 8, 2023 Chief Executive Officer, Director
SRZN Surrozen, Inc./DE May 18, 2023 1 $0 4 May 19, 2023 Director
NGM NGM BIOPHARMACEUTICALS INC Mar 2, 2023 3 $0 4 Mar 6, 2023 Chief Executive Officer, Director
SRZN Surrozen, Inc./DE Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
NGM NGM BIOPHARMACEUTICALS INC Mar 3, 2022 1 $0 4 Mar 4, 2022 Chief Executive Officer, Director
NGM NGM BIOPHARMACEUTICALS INC Dec 29, 2021 4 $138K 4 Dec 30, 2021 Chief Executive Officer, Director
NGM NGM BIOPHARMACEUTICALS INC Nov 18, 2021 3 -$187K 4 Nov 19, 2021 Chief Executive Officer, Director
SRZN Surrozen, Inc./DE Aug 11, 2021 0 $0 3 Aug 16, 2021 Director